Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Hillcrest Medical Blvd
Waco, TX 76712Phone+1 254-202-4816Fax+1 254-756-2047
Education & Training
- Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
- McGovern Medical School at UTHealthClass of 2012
Certifications & Licensure
- TX State Medical License 2017 - 2025
- PA State Medical License 2016 - 2017
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 384 citationsMelanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Monica V. Estrada, Roberto Salgado, Violeta Sanchez, Deon B. Doxie
Nature Communications. 2016-01-29 - 9 citationsERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanomaKatherine E. Hutchinson, Douglas B. Johnson, A. Johnson, Violeta Sanchez, Maria G. Kuba
Oncotarget. 2015-06-13 - 16 citationsCadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.A. Johnson, Jesse P. Wright, Zhiguo Zhao, Tatsuki Komaya, Alexander A. Parikh
Histopathology. 2015-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: